Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Platelet function defects in adolescents with heavy menstrual bleeding
H. L. Mills
,
M. S. Abdel-Baki
, J. Teruya
, J. E. Dietrich
, M. D. Shah
, D. Mahoney
, D. L. Yee
, L. V. Srivaths
Division of Hematology & Oncology
Siteman Cancer Center
Neurofibromatosis (NF) Center
Brain Tumor Center
Research output
:
Contribution to journal
›
Article
›
peer-review
35
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Platelet function defects in adolescents with heavy menstrual bleeding'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Abnormal Uterine Bleeding
100%
Platelet Function Defect
100%
Whole Blood
33%
Blood Platelets
33%
Platelet Aggregometry
33%
Patient Outcomes
11%
Clinical Features
11%
Improved Outcomes
11%
Medical Records
11%
Patient Demographics
11%
Nineteen
11%
Incidence Rate
11%
Von Willebrand Disease
11%
Institutional Review Board
11%
Hormonal Therapy
11%
Adult Women
11%
Appropriate Management
11%
Institutional Experience
11%
Intranasal
11%
Pediatric Gynecology
11%
Pediatric Hematology
11%
Bleeding Disorders
11%
Bleeding Complications
11%
Desmopressin (DDAVP)
11%
Antifibrinolytic Agents
11%
Coagulation Factor Deficiency
11%
Secretion Defect
11%
Thrombocytopaenia
11%
Rate-2
11%
Laboratory Results
11%
Outcome Information
11%
Second-tier Test
11%
Medicine and Dentistry
Thrombocyte Function
100%
Menorrhagia
100%
Platelet
33%
Secretion (Process)
11%
Prevalence
11%
Clinical Feature
11%
Prospective Study
11%
Bleeding
11%
Medical Record
11%
Blood Clotting Factor
11%
Von Willebrand Disease
11%
Hormone Therapy
11%
Thrombocytopenia
11%
Bleeding Disorder
11%
Antifibrinolytic
11%
Pediatric Gynecology
11%
Pediatric Hematology
11%
Desmopressin
11%
Pharmacology, Toxicology and Pharmaceutical Science
Menorrhagia
100%
Prospective Study
11%
Bleeding
11%
Prevalence
11%
Clinical Feature
11%
Thrombocytopenia
11%
Hormone Cancer Therapy
11%
Antifibrinolytic Agent
11%
Bleeding Disorder
11%
Blood Clotting Factor
11%
Desmopressin
11%
Von Willebrand Disease
11%